{"disease":{"id":"non-metastatic-disease","name":"non metastatic disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04671693","title":"A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT06933966","title":"Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT07420439","title":"Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":108,"lead_sponsor_name":"Intergroupe Francophone de Cancerologie Thoracique","has_results":false},{"nct_id":"NCT05375994","title":"Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":85,"lead_sponsor_name":"Verastem, Inc.","has_results":false},{"nct_id":"NCT06917573","title":"PALACE: Cemiplimab Trial According to ctDNA Levels","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"Fundación GECP","has_results":false},{"nct_id":"NCT05648370","title":"Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT06813664","title":"ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT05429320","title":"A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}